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The observed differences in immune
response gene expression could be due
to various receptors activating the p38/
PMK-1 MAP kinase cascade in addition
to parallel alternative immune pathways.
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Herpesviruses subvert immune cell activation by inhibiting NK cell receptor (NKG2D)-activating ligands such
as MICB. A human cytomegalovirus microRNA was recently shown to repress MICB expression. Nachmani
et al. (2009) extend this finding to two other human herpesviruses, providing evidence for a conserved func-
tional role of viral microRNAs despite no sequence conservation among them.MicroRNAs (miRNAs) are small noncod-
ing RNAs of 22 nucleotides expressed
by virtually all multicellular organisms.
They provide an ancient but continuously
adapting mechanism for the regulation of
gene expression. Recently, they have
been identified as key regulators in nearly
all biological processes, including cellular
differentiation, proliferation, apoptosis,
metabolism, and regulation of the immune
response. In humans, they are believed to
regulate 30% of all cellular genes (for
a review, see Bartel, 2004).
Herpesviruses are large DNA viruses
that have coevolved with their hosts over
millions of years. Humans can be infected
with eight different herpesviruses, which,
upon primary infection, establish lifelong
latency. The fact that the immune systemfails to efficiently control viral reactivation
from latency often leads to recurrent in-
fections and disease. Herpesviruses have
evolved a robust set of strategies to
counteract the vast repertoire of immune
response mechanisms. Since the
discovery of virally encoded miRNAs in
members of the herpesvirus family (Pfeffer
et al., 2004), it has been tempting to
assume that they regulate not only the life
cycle of the virus, but also the interaction
between viruses and their hosts, including
immune control of virus infection. So far,
more than 50 viralmiRNAs have been iden-
tified in 5 human herpesviruses, including
human cytomegalovirus (HCMV), Epstein-
Barr virus (EBV), and Kaposi’s sarcoma-
associated herpesvirus (KSHV), as well as
in herpes simplex virus 1 and 2 (HSV-1/-2).Cell Host & MicroSince miRNAs can be efficiently tar-
geted with chemically modified antisense
oligonucleotides, so-called antagomirs
(Krutzfeldt et al., 2005), viral miRNAs
present themselves as interesting candi-
dates for novel antiviral drugs. However,
in order to develop antiviral drugs based
on viral miRNAs, a detailed understanding
of their targets and function is required.
Since only a few bases of a miRNA define
its target specificity, identification of
miRNA targets by computational means
is often difficult. For cellular miRNAs,
such bioinformatic algorithms rely heavily
on evolutionary conservation of both
miRNAs and their targets. Since viral
miRNAs show no or very minimal
sequence conservation, only very few
targets of herpesvirus miRNAs have sobe 5, April 23, 2009 ª2009 Elsevier Inc. 315
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Figure 1. Selective Targeting of NKG2D Ligand MICB by Herpesviral MiRNAs
Human ligands for NKG2D receptor are targeted by herpesviruses, which leads to prevention of their expression on the cell surface and avoidance of immune cell
activation. Usually, more than one NKG2D ligand is targeted by herpesviral immunoevasion proteins. In contrast to the immunoevasion proteins, three
herpesviruses—HCMV, EBV, and KSHV—encode miRNAs, which selectively affect translation of MICB mRNA. All three miRNAs (HCMV miR-UL112, EBV
miR-BART2-5p, and KSHV miR-K12-7) target the 30-untranslated region (30UTR) of MICB at unique nonoverlapping sites in close proximity to the coding
sequence. Unlike cellular miRNAs (data not shown), viral miRNAs do not target MICA.far been identified (reviewed by Gottwein
and Cullen, 2008).
NKG2D is a potent activating receptor
on NK cells and a costimulatory receptor
on CD8+ T cells. Through its ability to
recognize a panel of ligands inducible by
stress, transformation, or infection, it
plays an important role in antitumor and
antiviral immune responses. In humans,
the NKG2D ligands are a diverse group
of proteins of the major histocompatibility
complex (MHC) class I-related chains
A (MICA) and B (MICB) and ULBP/RAET
families (Gonzalez et al., 2008). To avoid
NKG2D-dependent immune cell activa-
tion, herpesviruses encode proteins that
mediate the retention and sequestration
of NKG2D ligands, thus preventing their
surface expression. Previously, Mandel-
boim and his group reported that the
stress-induced NKG2D ligand MICB is
efficiently targeted by HCMV miRNA
miR-UL112, resulting in significantly re-
duced susceptibility of infected cells to
NK cell killing (Stern-Ginossar et al., 2007)
(Figure 1). MiR-UL112 targets not only
MICB but also the viral transactivator
IE72 (Grey et al., 2007). Therefore, a single
viral miRNA regulates both viral and host
gene expression. Further on, they demon-
strated that the two NK cell ligands, MICB316 Cell Host & Microbe 5, April 23, 2009 ª2009 Elsevier Inc.30-untranslated region (30UTR) of MICB
and do so at unique nonoverlapping sites
in close proximity to the coding sequence.
The lack of sequence homology indicates
that targeting a single host immune gene
might represent both coevolution and
individual convergent evolution of various
herpesviruses. Also, this marks MICB as
a key player in NK cell-mediated killing
during herpesviral infection. This is further
emphasized by the fact that both KSHV
and HCMV encode proteins to downregu-
late MICB expression by posttranslational
means. However, these proteins, K5 (of
KSHV) and UL16 (of HCMV), are less
restricted compared to the viral miRNAs
and mediate the sequestration not only
of MICB, but also of other NKG2D ligands.
It will be interesting to study whether EBV
also shares this strategy.
In addition, orthologous targeting of the
samehostgeneby two independentmech-
anisms evokes further questions, such as:
1. Why do these viruses put so much
effort in targeting the same gene
by at least partially redundant
mechanisms?
2. What is so special about MICB
within the large group of stress-
induced NKG2D ligands that threeand MICA, are both also a major target for
multiple cellular miRNAs (Stern-Ginossar
et al., 2008). Thus, they elucidated a
cellular mechanism by which cells regu-
late and prevent accidental NK cell-medi-
ated killing, indicating that HCMV has
usurped this cellular mechanism in order
to target these ligands. While both MICA
and MICB are regulated by cellular
miRNAs, HCMV miR-UL112 revealed a
striking preference for regulating MICB.
In this issue of Cell Host & Microbe
(Nachmani et al., 2009), Mandelboim
and colleagues extend their study to
miRNAs of two other human herpesvi-
ruses: EBV and KSHV. Using a bioinfor-
matic and functional approach, they iden-
tified EBV miR-BART2-5p and KSHV
miR-K12-7 as both selectively targeting
MICB but not MICA (Figure 1). The
expression of these two miRNAs resulted
in a dramatic reduction of MICB levels on
the cell surface and a significantly
reduced NK cell killing of these cells.
Most importantly, their study provides
the first example of a functional con-
servation among various herpesvirus
miRNAs downregulating a single host
immune gene. None of the miRNAs
show any sequence homology. However,
remarkably, all three miRNAs target the
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Previewsdifferent herpesviruses indepen-
dently recognized the need to
target it with a miRNA?
The picture of a conserved functional
role of viral miRNAs is emerging. Three
human herpesviruses prevent NK cell-
mediated killing of infected cells by tar-
geting the same stress-induced NK cell
ligand. In addition, a number of herpesvi-
ruses have been found or predicted to
target their major transactivators using
viral miRNAs (reviewed in Gottwein and
Cullen, 2008). Low-level expression of
these proteins in latently infected cells
might trigger an immune response. There-
fore, one is tempted to speculate that
one functional role of viral miRNAs is to
prevent both NK and T cells from recog-
nizing infected cells during a time when
the expression of viral proteins preventing
this recognition would lead to antigen
presentation and elimination of the in-
fected cells by cytotoxic T cells. Com-pared to viral immunoregulatory proteins,
the advantage of viral miRNAs may be
their poor immunogenicity, which could
be of particular importance in cells under-
going reactivation of latent virus in immu-
nocompetent host.
A better understanding of the linkage
between immune response functions
and viral miRNAs requires additional
considerations. As for the viral immunoe-
vasion proteins, major insights still have
to come from the analysis of the role of
viral immunoregulatory miRNAs in vivo.
In addition, we need to understand the
meaning of redundancy of viral immunoe-
vasion of NKG2D. The answers to these
important questions will be clarified by
animal models looking at the transition
from acute infection to viral latency and
reactivation thereof.
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